Australia markets close in 38 minutes

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
23.97-0.55 (-2.24%)
At close: 04:00PM EDT
23.93 -0.04 (-0.17%)
After hours: 04:25PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.50B
Enterprise value 2.08B
Trailing P/E 22.83
Forward P/E 33.56
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.05
Price/book (mrq)4.56
Enterprise value/revenue 3.98
Enterprise value/EBITDA 16.87

Trading information

Stock price history

Beta (5Y monthly) 0.48
52-week change 32.94%
S&P500 52-week change 324.49%
52-week high 334.28
52-week low 320.84
50-day moving average 323.91
200-day moving average 326.60

Share statistics

Avg vol (3-month) 31.11M
Avg vol (10-day) 31.7M
Shares outstanding 5104.11M
Implied shares outstanding 6106.5M
Float 885.36M
% held by insiders 111.38%
% held by institutions 184.82%
Shares short (15 Apr 2024) 421.12M
Short ratio (15 Apr 2024) 424.85
Short % of float (15 Apr 2024) 428.67%
Short % of shares outstanding (15 Apr 2024) 420.34%
Shares short (prior month 15 Mar 2024) 420.22M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 22.54%
Operating margin (ttm)20.09%

Management effectiveness

Return on assets (ttm)11.96%
Return on equity (ttm)21.91%

Income statement

Revenue (ttm)523.53M
Revenue per share (ttm)5.12
Quarterly revenue growth (yoy)39.00%
Gross profit (ttm)N/A
EBITDA 122.8M
Net income avi to common (ttm)117.2M
Diluted EPS (ttm)1.05
Quarterly earnings growth (yoy)74.80%

Balance sheet

Total cash (mrq)410.76M
Total cash per share (mrq)3.94
Total debt (mrq)76k
Total debt/equity (mrq)0.01%
Current ratio (mrq)5.18
Book value per share (mrq)5.27

Cash flow statement

Operating cash flow (ttm)124.84M
Levered free cash flow (ttm)123.86M